prior to vaccination showed poorer responses to the A-strains of the vaccine at five weeks (around the time of the peak response) and five months post-vaccination (indicating the decay in antibody response over time) (Burns, Carroll, Drayson, Whitham, & Ring, 2003) . This was replicated for the numbers and severity of stressful life events prior to vaccination with the response to the B/Shangdong influenza strain at both five weeks and five months postvaccination (Phillips, Burns, Carroll, Ring, & Drayson, 2005) . Similarly, in a study of the effects of daily stress and feelings of being overwhelmed during the 10 days following vaccination, higher stress ratings were associated with lower antibody titres to the A/New Caledonia strain at both one and four months following vaccination (Miller et al., 2004) . These studies provide evidence that stressful life events both preceding and in the period immediately following vaccination can influence the antibody response. They also show that both the peak antibody response at around four weeks and the decay in antibody protection over time are influenced by stressful life events,
Timing of stress assessment
This issue of the timing of stress assessment has been developed further in studies of different vaccinations including hepatitis B, which is useful in this context, as the vaccination schedule consists of three inoculations over a six month period. The largest of these studies examined the association between life events stress and the final antibody titre in students, vaccinated either in the past twelve months or at least thirteen months previously (Burns, Carroll, Ring, Harrison, & Drayson, 2002) . Whereas life events exposure was not related to antibody response in the recently vaccinated cohort, participants in the earlier vaccinated cohort who reported higher life events over the past year were over twice as likely to show an inadequate antibody titre as those with lower life events exposure. This finding suggests that the immunogenicity, the ability to induce a strong vaccination response, of hepatitis B vaccination may initially override the influence of life events stress, although there was also more power to detect effects in the earlier vaccinated cohort as more participants exhibited inadequate antibody titres (Burns, et al., 2002) .
Nevertheless, this study provides some evidence that psychosocial stress in the period following Post-print, not final published version. Cite this article as: Phillips, A.C. (2011, invited Social & Personality Compass (Health Section), 5, 621-633. Review. http://dx.doi.org/10.1111 /j.1751 -9004.2011 vaccination can have effects on the rate of deterioration of antibody protection (Burns, Carroll, Ring, & Drayson, 2003) .
In a study where a low dose of hepatitis B vaccine was administered, a higher stress index, comprising life events exposure and psychological symptoms, measured at two months postvaccination (thus considering the period post-vaccination) was associated with a poorer final six month antibody response, and the stress index at six months also tended to relate negatively to antibody response (Jabaaij et al., 1993) . However, as only the final antibody titre was measured, it is difficult to determine whether, in this instance, stress predominantly influenced initial formation or maintenance of antibody levels. Also, the inclusion of psychological symptoms in the composite stress index makes it difficult to ascribe this finding to any specific aspect of stress (Burns, Carroll, Ring, et al., 2003) . A similar study using the full dosage hepatitis B vaccination did not yield any significant stress effects (Jabaaij et al., 1996) , although it is possible that this was due to the absence of a two-month assessment of stress, which was the main predictor of antibody response in the previous study by this group. In a study measuring perceived stress and anxiety during the vaccination period, i.e. post-vaccination, these were not associated with the final antibody response to hepatitis B (Glaser et al., 1992) . Further, life events stress prior to vaccination and perceived stress at the time of the initial vaccination were not related to antibody status five months following the initial inoculation in a more recent study (Marsland, Cohen, Rabin, & Manuck, 2001 ). On the whole, this would suggest either that stress prior to vaccination is less detrimental to the antibody response than stress post-vaccination, or that it is difficult to observe stress effects early on with the full dose hepatitis B vaccination, due to its immunogenicity. Given the findings with the influenza vaccination and stress, this latter seems the more likely explanation.
In contrast, one study reported a positive association between perceived life event stress, depression and anxiety during the vaccination period and hepatitis B antibody status nine months following the initial vaccination (Petry, Weems, & Livingstone, 1991) . This anomalous result Post-print, not final published version. Cite this article as: Phillips, A.C. (2011, invited article has been attributed to the relatively low levels of stress experienced by the participants in this study, suggesting that moderate levels of life change stress experienced during the initial stages of antibody formation may be beneficial to the antibody response, although high levels may be detrimental (Petry, et al., 1991) . Such an interpretation receives support from animal research where moderate stress at the time of vaccination has been associated with an enhanced antibody response (see e.g. (Dhabhar & McEwen, 1996) .
Intensity and chronicity of stress and the vaccination response
Following on from the discussion above, such that moderate or less severe stress at the time of vaccination might actually have a beneficial effect, it has been suggested in recent years that acute (minutes or hours) stress may be immune enhancing when experienced close to the immune challenge. Such immune enhancement by acute stress would be an adaptive mechanism, and might be regarded as an integral component of the fight or flight response, and circumstances that elicit such a response are likely to also involve exposure to antigens and, therefore, a robust immune response would be adaptive for survival (Dhabhar & McEwen, 1996) . Recently, our laboratory examined the effect of acute psychological stress on antibody response to vaccination in humans. Participants completed a 45 min time pressured, socially evaluated mental arithmetic task, or a resting control period, immediately prior to influenza vaccination. An enhancement of the antibody response to one of the influenza viral strains was found in women in the psychological stress group compared to control (Edwards et al., 2006) .
Different types of vaccinations

Primary and secondary vaccinations
As indicated above, vaccination with an antigen to which the participant has not been previously exposed induces a primary antibody response whereas vaccination against more common pathogens such as influenza, induce a secondary immune response. By examining the effect of stress on both primary and secondary immune responses, we can begin to determine which aspects of the immune response are most susceptible to stress-induced modulation.
Hepatitis B vaccination has been used in this context due to the vaccination schedule and the low likelihood of prior naturalistic exposure to this pathogen. In an earlier study, individuals reporting higher mean perceived stress and anxiety over the vaccination period were less likely to have sero-converted (produced a protective antibody level) by the time of the second inoculation (Glaser, et al., 1992) . Whereas, an emotional disclosure intervention group did not differ from controls in antibody levels at the time of the second inoculation (Petrie, Booth, Pennebaker, Davison, & Thomas, 1995) . However, psychological stress levels were not measured, making it difficult to interpret these data. More recently, we have used hepatitis A as a primary antigen. Students who reported a higher number and severity of life events had a poorer antibody response to hepatitis A at the 18-week, but not 4-week, follow-up, suggesting stress can impact upon the maintenance of antibody levels (Gallagher, Phillips, Ferraro, Drayson, & Carroll, 2008a) . Early studies using the vaccination model used novel non-pathogenic antigens to examine the antigen-specific antibody response. Keyhole limpet hemocyanin (KLH), a protein, has been used in this context; the KLH-specific IgG antibody response was lower at eight weeks, but not three weeks, post-vaccination in participants reporting fewer positive life events prior to vaccination (Snyder, Roghmann, & Sigal, 1990) .
The consensus of this evidence suggests that stress can influence the primary antibody response, particularly the maintenance of responses to novel antigens. It also supports the idea that life events stress effects are more likely to be evident with novel vaccine types . As discussed above, the secondary antibody response to hepatitis B vaccination has produced mixed results, but there appears to be stronger evidence for a negative effect of psychological stress on the secondary response to this antigen (Burns, Carroll, Ring, et al., 2003; Cohen, Miller, & Rabin, 2001) , in line with the findings for the influenza vaccine.
Thymus-dependent and independent vaccinations
A further advantage to the vaccination model is that there are different types of vaccination, which can be used to help elucidate which cells involved in the vaccination response are influenced by psychological factors. Most vaccinations, which consist of inactivated or dead viruses like influenza, induce a thymus-dependent antibody response, as described above. A few vaccinations, however, protect against bacterial infections or toxins like meningococcal A or tetanus, respectively, which do not require T-cell help. There are also conjugate vaccines, in which substances that elicit a T-cell response are conjugated to a thymus-independent pathogen, such as a protein, in order to boost the efficiency of the antibody response against the thymusindependent pathogen. If psychological factors are consistently associated with the response to thymus-dependent and conjugate vaccinations but not with thymus-independent response, this would imply that it is T-cells that are particularly liable to psychological influence.
Indeed, there is evidence to suggest that stress may exert its effects mainly on T-cells; we showed that higher frequency and intensity of stressful life events were associated with a poorer response to influenza and meningococcal C (following previous conjugate meningococcal C vaccination), but not to thymus-independent meningococcal A .
Similarly, no association was found between stress and antibody response to a thymusindependent pneumonia vaccination in pre-school children (Boyce et al., 1995) . However, as older care-givers have been reported to show poorer maintenance of antibody levels over time following pneumonia vaccination than controls (Glaser, Sheridan, Malarkey, MacCallum, & Kiecolt-Glaser, 2000) , it is possible that other factors such as age and severity of stress may interact to impair antibody-mediated immunity more generally than just the T-cell response.
It should be noted that in the study of caregivers and the pneumonia vaccination, perceived stress did not differ between the caregiver and controls, but there was a significant difference in social support. This might suggest that thymus-dependent vaccinations are susceptible to the effects of stressful life events, but that thymus-independent vaccinations are more vulnerable to other psychosocial factors such as lower social support. There is some evidence for this suggestion.
In our own laboratory, we found that social support, but not life events stress, was positively associated with the response to a thymus-independent pneumococcal vaccine in young healthy students (Gallagher, Phillips, et al., 2008a; Gallagher, Phillips, Ferraro, Drayson, & Carroll, 2008b ).
The comparison between thymus-dependent and -independent vaccination responses suggest that both types of response are susceptible to psychosocial influence, but that there are key variables which influence whether an effect on vaccination response is observed. These include: the type of psychosocial factor studied (i.e. stress versus social support), and the age of the population sampled. This article will now address each of these issues in turn.
Other psychosocial factors and vaccination
Social support
The support of friends and loved ones is an important determinant of immune health. Studies have assessed both functional social support, a measure of the quality and availability of social resources a person has, and structural social support, the number of friends a person can call on, in the context of vaccination. First, students reporting greater social support demonstrated a stronger combined immune response to the third inoculation of the three-dose hepatitis B vaccination (Glaser, et al., 1992) . Second, loneliness and smaller social network size were associated with a poorer antibody response to the A/New Caledonian strain of the influenza vaccination in college students (Pressman et al., 2005) . Third, students with greater functional social support showed higher titres to the A/Panama influenza strain at both five weeks and five months following vaccination . In older nursing home residents, social support was also negatively correlated with pre-and post-vaccination titres against the A/Panama influenza strain yet positively with pre-vaccination antibody titres against the A/New Caledonia strain (Moynihan et al., 2004) , a finding which even the authors were unable to explain. Along with the caregiver study discussed above, these studies generally show that a lack of social support has a strong negative impact on antibody levels following vaccination.
Marriage is also a source of social support. In our own work, older adults who were married, and particularly those who were happily married, showed a better antibody response to the influenza vaccination than those who were unmarried or less happily married (Phillips et al., 2006) . However, more general functional social support and social network size was not associated with antibody response in this older population (Phillips, et al., 2006) . These findings perhaps lend weight to the suggestion that the population studied influences which psychosocial factors are important for the vaccination response. The impact of age will be further discussed later in this article.
Personality
Personality factors, although often examined in the context of health outcomes (see e.g., (Smith, Glaser, Ruiz, & Gallo, 2004) have scarcely been investigated relative to the vaccination response. First, among a group of 12-year old girls, those characterized by higher internalizing scores and lower self-esteem at baseline exhibited lower antibody titres following rubella vaccination (Morag, Morag, Reichenberg, Lerer, & Yirmiya, 1999) . A similar concept, neuroticism, was negatively associated with both the peak antibody response to the A/Panama strain of an influenza vaccination, and the maintenance of antibody titres to this strain in students . Among female graduate students, trait negative affect/mood was negatively associated with the antibody response to the second hepatitis B injection (Marsland, et al., 2001) . Further, independently of negative affect, trait positive affect was associated with a better antibody response following a second hepatitis B vaccination in graduate students (Marsland, Cohen, Rabin, & Manuck, 2006) . Thus, both negative and positive traits appear to be able to influence this aspect of immune function and disease protection.
However, in exercising and sedentary elderly individuals, dispositional optimism was not found to be associated with antibody titres following influenza vaccination (Kohut, Cooper, Nickolaus, Post-print, not final published version. Cite this article as: Phillips, A.C. (2011, invited article measures of personality studied, or the different ages of the populations used, which will now be discussed in more detail.
Vaccination response in older adults
It is important to study the psychological influences on the antibody response to vaccination in older adults, given that they have less efficient immune systems due to immune ageing, which contributes to increased infectious disease susceptibility (Ginaldi, Loreto, Corsi, Modesti, & De Martinis, 2001 ). Further, it is possible that ageing of the immune system and stress interact such that stress takes its greatest toll on immunity in those who have existing immunosenescence (Graham, Christian, & Kiecolt-Glaser, 2006; Phillips, Burns, & Lord, 2007) .
Caregiving
The vaccination response in older adults has mainly been considered in the context of the chronic stress of caregiving for a spouse with dementia. Studies have shown that caregivers have poorer antibody responses to vaccination in comparison to matched control participants (Glaser, et al., 1992; Glaser, et al., 2000; . Similarly, caregivers who exhibited repetitive negative thoughts about their situation had lower antibody titres following influenza vaccination (Segerstrom, Schipper, & Greenberg, 2008) . However, in younger populations, such as Multiple Sclerosis spousal caregivers, there was no difference in antibody response to influenza vaccination between caregivers and controls (Vedhara et al., 2002) . This raises the issue of whether the poor antibody response observed in older caregivers is, to an extent, a function of an interaction between chronic stress exposure and immunosenescence (Graham, et al., 2006) . A recent study from our group supports such a notion. Secretion rates of secretory immunoglobulin-A (S-IgA), a salivary antibody, were found to be lower in non-routine caregivers relative to controls, but only for the oldest (aged 63 years) of three distinct age cohorts (Gallagher et al., 2008) .
There is an alternative explanation for the discrepancy in outcomes among the caregiver vaccination studies. Rather than immune ageing, perhaps it is the intensity of the stress experienced that determines whether caregiving becomes an issue for immunity (Vedhara, et al., 2002) . Dementia is a disease characterised by much more severe cognitive and behavioural disturbances than multiple sclerosis (Gregory & Hodges, 1996; Keegan & Noseworthy, 2002; Neary et al., 1998; Poser et al., 1983) , and older spousal caregivers of dementia patients have been found to report greater distress than younger multiple sclerosis caregivers (Vedhara, et al., 2002) . Further, the results of two recent meta-analyses indicate that caregivers of dementia patients generally experience greater burden and report more symptoms of depression than those caring for non-dementia, e.g., cancer, patients, (Pinquart & Sorensen, 2003a , 2003b . Thus, it might be hypothesized that, irrespective of the caregiver's age, caring for someone with severe cognitive and behavioural problems will compromise immunity.
We have been able to test this hypothesis recently using a caregiving model in younger adults; young parents caring for children with developmental disabilities. Dealing with severe cognitive difficulties and behaviours that are problematic and distressing are the main challenges of such caring (Floyd & Gallagher, 1997; Hastings, Daley, Burns, & Beck, 2006; Higgins, Bailey, & Pearce, 2005; Maes, Broekman, Dosen, & Nauts, 2003) . In our own studies of 30 caregivers for a child with a developmental disability (mainly Autism) versus matched controls, we have demonstrated that caregivers report high levels of stress, anxiety, depression, child problem behaviours, and low levels of social support. These caregivers also exhibited a poorer antibody response to a pneumonia vaccination than parents caring for typically developing children at both one and six months post-vaccination (Gallagher, Phillips, Drayson, & Carroll, 2009) . Of the psychological variables considered, child problem behaviours mediated this effect. In addition, within the caregivers, parents reporting more child conduct problems, a component of the child problem behaviour measure, mounted a poorer antibody response at 1-month than parents reporting less conduct problems (Gallagher, Phillips, Drayson, & Carroll, 2009) . Similarly, these parents mounted a poorer antibody response to the B/Malaysia strain of an influenza vaccine at one and six months postvaccination, which again appeared to be mediated by differences in child problem behaviours (Gallagher, Phillips, Drayson, & Carroll., 2009 ).
These recent findings in younger caregivers reinforce the hypothesis that an ageing immune system is not a pre-requisite for a poor response to medical vaccination in caregivers.
Nevertheless, among our parental caregivers, older caregivers tended to have a poorer antibody response to B/Malaysia at 1-month, suggesting that we cannot dismiss the hypothesis that chronic stress and immunosenescence may have synergistic effects (Graham, et al., 2006) .
Life events stress in older adults
Caregiving is a very specific stressor, and care-givers are likely to differ from the general population in ways other than the stress of care-giving, for example, in the amount of social support they receive. Research examining the impact of more general psychological stress on antibody levels following vaccination is sparse. However, it is important to study older adults in this context as they are likely to have different stress exposure histories than younger samples (Carroll, Phillips, Ring, Der, & Hunt, 2005) as well as immune ageing (Ginaldi, et al., 2001) .
One study found that older adults reporting higher perceived stress had lower antibody levels following influenza vaccination (Kohut, et al., 2002 ). As the baseline antibody level prior to vaccination was not known, however, the impact on the actual response to the vaccine could not be assessed. Similarly, nursing home residents who reported higher levels of perceived stress had lower pre-vaccine antibody titres to two influenza vaccine components (Moynihan, et al., 2004) . However, it is not clear what this means, given that pre-vaccine titres could reflect differences in prior vaccine history or exposure. More recently, we observed that the stress of bereavement in the year prior to influenza vaccination was associated with a poorer antibody response to two of the influenza strains in a community sample of 184 adults aged 65 and over (Phillips, et al., 2006) . Although overall negative life events exposure was not associated with vaccine response in this study, the effect found for bereavement suggests that stress is related to pervasive immune effects throughout the life course, although what constitutes life events stress will vary depending on the age of the sample studied.
Future Directions
The studies reviewed above show the strong associations between psychological stress, other One study showed an improvement in the ability of older caregivers for a spouse with dementia to mount a four-fold increase in antibody titre following influenza vaccination relative to matched controls, although the mechanisms of effect were unclear and the intervention group were not randomly sampled (Vedhara et al., 2003) . Similarly, participants taking part in a written emotional disclosure intervention, where they wrote about their emotions about a previously undisclosed stressful event, showed significantly higher antibody titres at four and six months following vaccination with hepatitis B compared to a control non-intervention group (Petrie, et al., 1995) . A different clinical application of the vaccination model has arisen from the positive immune effects demonstrated in response to acute stress (Edwards, et al., 2006) . These preliminary findings suggest that the development of such a behavioural challenge that could be applied in General Practitioner settings could be a way forward for improving the vaccination response. This would be particularly important for groups at risk of infectious disease such as older adults, the bereaved, and care-givers. At this stage, more work is required to establish exactly what types of intervention in which age groups and are likely to be the most beneficial for psychological, and hence immunological, health.
Conclusion
In conclusion, vaccination has had a substantial impact on public health, although not everyone mounts a satisfactory and protective antibody response to vaccination. This increasingly appears to be the case with progressing age. Studying antibody responses to vaccination is now contributing to the understanding of how psychosocial exposures can influence immunity and, consequently, resistance to disease. The current challenges are to unravel the underlying mechanisms and to develop and apply feasible behavioural interventions to boost the response to vaccination and, thus, optimize our resistance against infectious disease.
